Mirxes, a spin-off of Singapore ’s Agency for Science, Technology and Research, will establish a foothold in Hong Kong this year to tap into the vast multi-cancer early-stage screening market in the Greater Bay Area.
Singaporean firm Mirxes enters Hong Kong to tap into growing multi-cancer early-stage screening market in Greater Bay Area
RELATED ARTICLES
Hong Kong’s Cathay Pacific investigates after passenger suffers suspected food poisoning
Malaysia woman claims a year of office bullying led her to vent frustration and hit young son
‘Why China?’ EU business group says strategic rethink may be needed for foreign investors
